Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

ByHeart Infant Formula Recall Expands After Botulism Bacteria Found in Labs

ByHeart expands its infant formula recall after tests detect botulism-causing bacteria linked to illnesses in dozens of babies.

International Business Times

12 Everyday Items That Became Illegal Overnight

We often take our mundane grocery store runs for granted. Generally, we assume that everything sitting on a retail shelf is safe, tested, and entirely legal to own. However, laws change much more rapidly than we realize. What was a household staple yesterday can easily become contraband today.

Budget and the Bees

Sarepta Secures FDA Nod For Elevidys Study To Reduce Liver Injury Risk

The U.S. Food and Drug Administration (FDA) on Tuesday approved dosing in Sarepta Therapeutics Inc.’s (NASDAQ:SRPT) Cohort 8 of ENDEAVOR (Study 9001-103).

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

'Catch Kits' for Fetal Remains Are Republicans' Latest Dystopian Plan To Punish Abortions

GOP lawmakers in Wisconsin and elsewhere are pushing the idea that abortions are a water quality issue.

Reason

The Surprising Way to Reduce Your Dementia Risk

Lower your dementia risk with this one hack.

Kiplinger

Can Your Pacemaker Be Hacked? The Hidden Threat in Connected Medical Devices

Imagine carrying a device inside your chest that keeps you alive, yet could be accessed by hackers. Pacemakers and other connected medical devices are designed...

Saving Advice

Why Is Biogen Stock Trading Higher After Semaglutide Alzheimer's Data?

Biogen Inc. (NASDAQ:BIIB) stock traded higher after Novo Nordisk A/S (NYSE:NVO) released disappointing topline results from the 2-year primary analysis of Evoke and Evoke+ phase 3 trials in early-stage symptomatic Alzheimer's disease.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

The Short-Sellers May Be Right About This Red-Hot Pharma Stock

Palvella Therapeutics (PVLA) is a clinical-stage biopharma stock with no revenue or FDA pipeline. However, the stock has exceptional price momentum with shares up 508% over the past year. PVLA is trading at a new 2-year high and has strong technical indicators. Palvella is highly speculative. It is suitable for...

Barchart

Months Before the ByHeart Recall, Babies Were Already Sick — Parents Ask Why Early Warning Signs Were Missed

ByHeart's voluntary recall of its infant formula this November has raised concerns after families reported babies falling ill months earlier, highlighting potential delays in outbreak detection and regulatory response.

International Business Times UK

Doctors respond to ‘data-free’ decision over menopause hormone therapy: ‘It’s not true’

Physicians say FDA panel conflated two issues and made baseless claims about unproven health benefits

The Guardian - US

Popular dessert bun recalled over potential health risk

The affected products were sold in 33 states across the U.S.

The Independent UK

Off-label use of COVID-19 vaccines was once discouraged but has become common amid new guidelines

Following the federal government’s changes to COVID-19 vaccine eligibility and recommendations in 2025, many people are wondering whether they can get COVID-19 vaccines for themselves or their children.

The Conversation

A popular supplement has been linked to the deaths of six people in California. But no one knows the exact danger it poses

Several states have banned kratom, an unregulated supplement, that has been linked to six deaths in Los Angeles County

The Independent UK

Number of infants hospitalized with botulism climbs to 31 as outbreak linked to recalled formula continues

The outbreak has affected 15 states with Texas seeing the most cases

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Recalled ice cream bars were sold to grocery stores nationwide

Benzinga

Short Seller Alleges Praxis Precision's Potential $3 Billion Drug 'A House Of Cards'

A short seller is challenging Praxis Precision Medicines Inc. (NASDAQ:PRAX) after the company claimed success from its Phase 3 trial of ulixacaltamide.

The Independent UK

RFK Jr updates CDC website to link vaccines to autism despite years of agency fighting misinformation

The website now states that “studies supporting a link have been ignored by health authorities.”

Barchart

This Leading Gene-Editing Stock Could Be Going Private. Should You Buy Its Shares First?

CRISPR Therapeutics is the subject of strong buyout speculation after earning FDA approval for a breakthrough gene-editing therapy.

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Why GRAIL Stock Could Be Biotech’s Next Big Breakout

Explore insider buying signals, a promising cancer detection biotech, and why the American Dream is still achievable—even in a down market.

Medical Daily

Gene Editing Medicine and Personalized Medicine: Breakthroughs Driving Health Innovation Gene Therapy to Transform Care

Explore how gene editing medicine and personalized medicine future breakthroughs are revolutionizing health innovation gene therapy, offering precise, transformative treatments and medical breakthroughs for complex diseases.

The Independent UK

Cheese recalled over potential serious health risk

The recalled cheese was sold in Oregon

The Conversation

I treat menopause and its symptoms, and hormone replacement therapy can help – here’s the science behind the FDA’s decision to remove warnings

For more than 20 years, hormone therapy for menopause has carried a warning label from the Food and Drug Administration describing the medication’s risk of serious harms – namely, cancer, cardiovascular disease and possibly dementia.

Kids Ain't Cheap

10 Common Baby Products Now Under FDA Scrutiny

Image source: shutterstock.com

International Business Times UK

With $199 Price, Ozempic Prescriptions Expected to Soar — Experts Warn of Risks

Novo Nordisk's new $199 offer for Ozempic and Wegovy aims to improve access for obesity and diabetes treatments, but experts warn of potential serious side effects.

The Independent UK

Dietary supplements recalled nationwide after 11 people sickened with salmonella

Three people have been hospitalized amid the latest salmonella outbreak

1 … 30 31 32 33

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations